ID
12804
Description
Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+; ODM derived from: https://clinicaltrials.gov/show/NCT01354457
Link
https://clinicaltrials.gov/show/NCT01354457
Keywords
Versions (1)
- 12/21/15 12/21/15 -
Uploaded on
December 21, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Lymphoblastic Leukemia NCT01354457
Eligibility Acute Lymphoblastic Leukemia NCT01354457
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
t-all
Data type
boolean
Alias
- UMLS CUI [1]
- C0023493
Description
meningeal involvement
Data type
boolean
Alias
- UMLS CUI [1]
- C0948840
Description
cd22 expression
Data type
boolean
Alias
- UMLS CUI [1]
- C3815865
Description
hiv positive
Data type
boolean
Alias
- UMLS CUI [1]
- C0019699
Description
Hepatitis
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0019196
- UMLS CUI [1,2]
- C0019163
Description
active infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Description
left ventricular ejection fraction
Data type
boolean
Alias
- UMLS CUI [1]
- C0428772
Description
contra-indication
Data type
boolean
Alias
- UMLS CUI [1]
- C1301624
Description
malignancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Description
psychological, familial, sociological or geographical condition potentially hampering compliance
Data type
boolean
Alias
- UMLS CUI [1]
- C1321605
- UMLS CUI [2]
- C0439801
- UMLS CUI [3]
- C0009488
Description
study subject participation status
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
Description
informed consent denied
Data type
boolean
Alias
- UMLS CUI [1]
- C0021430
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT01354457
- StudyEvent: Eligibility
C0277556 (UMLS CUI [2])
C0332168 (UMLS CUI [1,2])
C0019163 (UMLS CUI [1,2])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])